ANNX Annexon Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ANNX

Price (delayed)

$3.83

Market cap

$193.39M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.6

Enterprise value

$85.2M

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on ...

Highlights
Annexon's EPS has increased by 24% YoY and by 23% QoQ
Annexon's debt has decreased by 5% YoY and by 2.5% from the previous quarter
The company's net income fell by 9% YoY but it rose by 2.1% QoQ
Annexon's quick ratio has decreased by 19% from the previous quarter and by 2.9% YoY
The equity has declined by 11% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.annexonbio.com
Peers: OVID

Key stats

What are the main financial stats of ANNX
Market
Shares outstanding
50.49M
Market cap
$193.39M
Enterprise value
$85.2M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.79
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$141.95M
EBITDA
-$138.64M
Free cash flow
-$122.84M
Per share
EPS
-$2.6
Free cash flow per share
-$2.25
Book value per share
$4.85
Revenue per share
$0
TBVPS
$5.21
Balance sheet
Total assets
$285.1M
Total liabilities
$53.9M
Debt
$32.86M
Equity
$231.19M
Working capital
$225.74M
Liquidity
Debt to equity
0.14
Current ratio
11.1
Quick ratio
10.9
Net debt/EBITDA
0.78
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-53.1%
Return on equity
-66%
Return on invested capital
-102.9%
Return on capital employed
-54%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ANNX stock price

How has the Annexon stock price performed over time
Intraday
2.41%
1 week
-5.9%
1 month
-28.94%
1 year
12.65%
YTD
-25.92%
QTD
-25.92%

Financial performance

How have Annexon's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$145.6M
Net income
-$141.95M
Gross margin
N/A
Net margin
N/A
The company's operating income fell by 11% YoY
The company's net income fell by 9% YoY but it rose by 2.1% QoQ

Growth

What is Annexon's growth rate over time

Valuation

What is Annexon stock price valuation
P/E
N/A
P/B
0.79
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Annexon's EPS has increased by 24% YoY and by 23% QoQ
The P/B is 12% lower than the last 4 quarters average of 0.9
The equity has declined by 11% since the previous quarter

Efficiency

How efficient is Annexon business performance
The return on invested capital has dropped by 67% year-on-year and by 10% since the previous quarter
The ROE has declined by 41% year-on-year
ANNX's ROA is down by 29% YoY

Dividends

What is ANNX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANNX.

Financial health

How did Annexon financials performed over time
Annexon's quick ratio has decreased by 19% from the previous quarter and by 2.9% YoY
Annexon's current ratio has decreased by 18% from the previous quarter and by 2.5% YoY
Annexon's debt is 86% less than its equity
The equity has declined by 11% since the previous quarter
The debt to equity has grown by 8% since the previous quarter but it has declined by 7% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.